|
A double-blind, placebo-controlled, multicenter study of fixed doses of paroxetine (10, 20, and 40 mg) given as a single oral dose daily, in the treatment of panic disorder. |
paroxetine |
MY1047/BRL-029060/1/CPMS-120 |
|
Panic Disorder |
Phase 3 |
|
|
|
|
An analysis-ready dataset is not available for this study. An annotated case report form, a reporting and analysis plan, a clinical study report, and a protocol are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
December 2014 |